Ulla Wartiovaara-Kautto

Hematologist, Associate Professor (tt) of Hematology, PI @waaralab HUH CCC & Uni Helsinki. Keen on patients, teaching, research. Germline, BMF, leukemias

[Nico Gagelmann @NicoGagelmann]

What a #EHA2025, with multiple high-quality simultaneous publications!

Congrats @EHA_Hematology and all presenters!

Here are the most impressive malignant hematology studies🧵

[Haematologica @Haematologica]

Read a new review on the most frequent and severe infections in sickle cell disease, to facilitate their diagnosis and treatment, and theoretically also their prevention through well-defined public health measures.
https://t.co/3TO2TxQys2

[British Journal of Haematology @BrJHaem]

Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France
https://t.co/fyt4SDLfwq

[ESH (Haematology) @ESHaematology]

📣 THE MAIN SCIENTIFIC TOPICS OF #ESHALL2025!
Register now ➡ https://t.co/w5UWiiKoQx
4th Translational Research Conference on ACUTE LYMPHOBLASTIC LEUKAEMIA
🗓️ May 22-24, 2025 - Malahide (Dublin) 🇮🇪
Chairs: Kathrin Bernt, @CoolsJn, @DombretHerve, @ullawk
#ESHCONFERENCES #LEUsm

[Carmelo Gurnari @CarmeloGurnari]

🚨🚨🚨happening now : Results of the PIVOT study of 5-HU in patients with HbSC in Ghana 🌍 #ASH24

[Carmelo Gurnari @CarmeloGurnari]

Wonderful and inspiring for the future the results of the COG AALL1731 study on blinatumomab in childhood ALL #ASH24
Next step👉 remodulation of CHT backbone

[ESH (Haematology) @ESHaematology]

📣 HERE ARE THE CONFIRMED SPEAKERS FOR #ESHALL2025
Learn more ➡ https://t.co/w5UWiiKWG5
4th Translational Research Conference on ACUTE LYMPHOBLASTIC LEUKAEMIA
🗓️ May 22-24, 2025 - Malahide (Dublin) 🇮🇪
Chairs: Kathrin Bernt, @CoolsJn, @DombretHerve, @ullawk
#ESHCONFERENCES #LEUsm

[Team Telomere @TeamTelomereInc]

Today we are sharing our Clinical Guidelines & the impact they have made across the world.

To order or download a copy of the CGs or our One Pagers head to our website site today ➡️ https://t.co/K9UFPZ8Stb

#TBDawareness #TeamTelomere15

[Olli Lohi @LohiOlli]

Congratulations @PolonenPetri
& others for groundbreaking work on the genomiccs fo T cell acute lymphoblastic #leukemia
https://t.co/3D64Dndum0

[Talha Badar @TalhaBadarMD]

Finally out ➡️ A huge shout out for @MRLitzow @eaonc @MayoCancerCare
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults | New England Journal of Medicine https://t.co/26exTImZdi

➡️ consolidation Blina improves OS in MRD-ve Ph-ve B-cell ALL

[Suomen Syöpäpotilaat @Syopapotilaat]

Vuonna 2022 Suomessa todettiin yhteensä 37 268 uutta #syöpä'ä, vuonna 2021 luku oli 36 543. Yli 320 000 syöpään sairastunutta suomalaista oli elossa vuoden 2022 lopussa.

👉 Tutustu @CancerRegFi Syöpä 2022 -raporttiin: https://t.co/hWFRHCOMME

[Olli Lohi @LohiOlli]

MYCT1 controls environmental sensing in hematopoietic stem cells and its silencing compromises
HSC expansion. Brilliant work by Mikkola lab @UCLA
https://t.co/tsZ0L0klN8

[FinnGen @FinnGen_FI]

FinnGen-tutkimus onnittelee tieteellistä johtajaamme Aarno Palotietä, jonka Helsingin yliopiston dosenttiyhdistys on nimittänyt vuoden dosentiksi!
@APalotie on suomalaisen genomitutkimuksen uranuurtaja ja tutkimusjohtaja @FIMM_UH @helsinkiuni . https://t.co/V6k8If69Mv

[Translational Immunology Research Program (TRIMM) @TRIMMprogram]

Unveiling the mechanism of genetic necrotizing fasciitis: https://t.co/SMvZ4TtiBX NFKB1truncations predispose carriers to excessive inflammation by disrupting two key immune pathways. Treatments targeting inflammasome and interferon signaling show therapeutic promise. Eklund lab

[Ulla Wartiovaara-Kautto @ullawk]

@AaronGoodman33 @AaronGoodman33 Why not including ERCC6L2 disease in this list? Causes BMF-> TP53-mutated MDS/AML (erythroid/M6). We have got information already on nearly 90 patients globally in a very short time! See also a stellar edtiorial @marrowgenes
https://t.co/3AXeiZ5Yem

[Carmelo Gurnari @CarmeloGurnari]

What a interesting talk on ERCC6L2 disease and outcomes of allo-HCT in both BMF and MN phases! Congrats to the Helsinki group! @helsinkiuni #ASH23

[Olli Lohi @LohiOlli]

"Kaikki kivet käännetään lasten parantamiseksi " @MKoskenvuo
@Syopasaatio

https://t.co/EAbWpjoeTP

[Olli Lohi @LohiOlli]

Excellent review on Shwachman-Diamond syndrome that manifests as neutropenia (BM failure), exocrine pancreatic insufficiency, skeletal abnormalities, and, in 10-30% of cases, myeloid neoplasms. Caused by mutations in SBDS, DNAJC21, EFL1, or SRP54 genes.
https://t.co/ujyqgLLHyD

[ASH @ASH_hematology]

ASH offers an array of resources for clinicians treating & individuals living with #sicklecell disease. The Society's transformative, multi-faceted, patient-centric initiative strives to improve health outcomes for this population. Learn more: https://t.co/vyahnH9v6U 1/2 🧵

[Nico Gagelmann @NicoGagelmann]

Allogeneic stem cell transplantation is the only potentially curative treatment for various blood cancers.

To cure, patients need YOU as donor of bone marrow or (much more frequently!) peripheral blood🙏

Register and be a real-world superhero!

Share and save lives🙏 #WMDD23